Dashboard E. coli
Repurposing candidates for E. coli
Escherichia coli
Approved medicines with AI-predicted activity ≥40% against E. coli, leaving out medicines that are already antimicrobials. Each is shown with what it is already used for. They are surfaced computationally for further investigation, not as treatments.
- AI-predicted activity ≥40%
- 467
- Existing antimicrobials set aside
- 103
- Needing review
- 28
- Repurposing candidates
- 336
Repurposing candidates for E. coli
AI prediction · nothing measuredAll 336 repurposing candidates for E. coli.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- Raloxifene HydrochlorideExisting use: Breast cancer, Osteoporosis, Postmenopausal osteoporosis40.7% AI-predicted activityagainst E. coli50+ registered studies
- Cetirizine HydrochlorideExisting use: Allergic conjunctivitis, Allergic disease, Allergic rhinitis and 6 more40.6% AI-predicted activityagainst E. coli50+ registered studies
- Levocetirizine DihydrochlorideExisting use: Allergic disease, Rhinitis, Allergic, Perennial, Seasonal allergic rhinitis and 2 more40.6% AI-predicted activityagainst E. coli50+ registered studies
- AvanafilExisting use: Erectile dysfunction, Impotence40.5% AI-predicted activityagainst E. coli24 registered studies
- Meclizine HydrochlorideExisting use: Allergic disease, Motion sickness, Nausea and 3 more40.5% AI-predicted activityagainst E. coli11 registered studies
- Ruxolitinib PhosphateExisting use: Alopecia areata, Cancer, Eczematoid dermatitis and 7 more40.5% AI-predicted activityagainst E. coli50+ registered studies
- AlpelisibExisting use: Breast cancer, Breast carcinoma, Breast neoplasm and 2 more40.5% AI-predicted activityagainst E. coli50+ registered studies
- TerconazoleExisting use: Triazole derivatives40.4% AI-predicted activityagainst E. coli10 registered studies
- EszopicloneExisting use: Insomnia40.4% AI-predicted activityagainst E. coli50+ registered studies
- Mivacurium ChlorideExisting use: Other quaternary ammonium compounds40.4% AI-predicted activityagainst E. coli14 registered studies
- DarolutamideExisting use: Cancer, Metastatic prostate cancer, Neoplasm and 4 more40.4% AI-predicted activityagainst E. coli50+ registered studies
- Sapropterin DihydrochlorideExisting use: Hyperphenylalaninemia, Phenylketonuria40.4% AI-predicted activityagainst E. coli50+ registered studies
- CiclesonideExisting use: Airway obstruction, Allergic rhinitis, Asthma and 3 more40.4% AI-predicted activityagainst E. coli50+ registered studies
- Methylnaltrexone BromideExisting use: Constipation, Opioid dependence40.3% AI-predicted activityagainst E. coli50+ registered studies
- ProtirelinExisting use: Tests for thyreoidea function40.3% AI-predicted activityagainst E. coli15 registered studies
- Dasabuvir SodiumExisting use: Chronic hepatitis C virus infection, Hepatitis C virus infection, Viral disease40.3% AI-predicted activityagainst E. coliNo documented evidence found
- FelodipineExisting use: Cardiovascular disease, Diabetes mellitus, Hypertension40.2% AI-predicted activityagainst E. coli28 registered studies
- IxabepiloneExisting use: Breast cancer, Breast carcinoma, Breast neoplasm and 2 more40.2% AI-predicted activityagainst E. coli50+ registered studies
- TravoprostExisting use: Glaucoma, Ocular hypertension, Open-angle glaucoma40.2% AI-predicted activityagainst E. coli50+ registered studies
- Pergolide MesylateExisting use: Parkinson disease40.2% AI-predicted activityagainst E. coli12 registered studies
- ApalutamideExisting use: Cancer, Metastatic prostate cancer, Neoplasm and 3 more40.1% AI-predicted activityagainst E. coli50+ registered studies
- PrednicarbateExisting use: Allergic conjunctivitis, Allergic rhinitis, Ankylosing spondylitis and 56 more40.1% AI-predicted activityagainst E. coli3 registered studies
- NilotinibExisting use: Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic myelogenous leukemia40.0% AI-predicted activityagainst E. coli50+ registered studies
- NisoldipineExisting use: Cardiovascular disease, Hypertension40.0% AI-predicted activityagainst E. coli6 registered studies